Tanaka Nobuyuki, Kikuchi Eiji, Kanao Kent, Matsumoto Kazuhiro, Shirotake Suguru, Kobayashi Hiroaki, Miyazaki Yasumasa, Ide Hiroki, Obata Jun, Hoshino Katsura, Hayakawa Nozomi, Kosaka Takeo, Oyama Masafumi, Miyajima Akira, Momma Tetsuo, Nakagawa Ken, Jinzaki Masahiro, Nakajima Yosuke, Oya Mototsugu
Department of Urology, Keio University School of Medicine, Tokyo, Japan; Department of Urology, Musashino Yowakai Hospital, Tokyo, Japan.
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Urol Oncol. 2014 Jan;32(1):48.e19-26. doi: 10.1016/j.urolonc.2013.07.003. Epub 2013 Sep 18.
Few studies have addressed the predictive value of positive urine cytology for prognosis in patients with upper tract urothelial carcinoma (UTUC). We investigated whether the status of preoperative urine cytology could provide additional prognostic information following radical nephroureterectomy (RNU).
The study included 474 patients with primary nonmetastatic UTUC (pTa-4N0M0) from a retrospective multi-institutional cohort. The median follow-up period was 35 months. Associations between the status of urine cytologic evaluation and outcomes were analyzed using multivariate Cox regression models. Urine cytology was evaluated preoperatively using voided samples. Disease recurrence was defined as any relapse in nonbladder lesions and was coded separately from intravesical recurrence.
Positive urine cytology was detected in 184 patients (38.8%) preoperatively. Disease recurrence occurred in 127 patients, while intravesical recurrence occurred in 219 patients; 83 patients died of UTUC during follow-up. Kaplan-Meier analysis revealed that only the incidence of intravesical recurrence was significantly associated with the status of urine cytologic evaluation (P = 0.024); the intravesical recurrence-free survival rates at 1 and 3 years following RNU were 61.4% and 46.2% in patients with positive urine cytology and 71.1% and 51.6% in their counterparts, respectively. Multivariate analysis showed that gender (hazard ratio [HR] = 1.74, 95% confidence interval [CI]; 1.28-2.43), tumor multifocality in RNU specimens (HR = 1.64, 95% CI; 1.09-2.47), and positive urine cytology (HR = 1.41, 95% CI; 1.08-1.85) were independent risk factors for subsequent intravesical recurrence.
The results showed the prognostic value of positive urine cytology in patients with primary UTUC, and preoperative positive urine cytology may be associated with a significant increase in the prevalence of intravesical recurrence following RNU.
很少有研究探讨尿细胞学阳性对上尿路尿路上皮癌(UTUC)患者预后的预测价值。我们研究了术前尿细胞学状态是否能在根治性肾输尿管切除术(RNU)后提供额外的预后信息。
本研究纳入了474例来自回顾性多机构队列的原发性非转移性UTUC患者(pTa - 4N0M0)。中位随访期为35个月。使用多变量Cox回归模型分析尿细胞学评估状态与预后之间的关联。术前使用晨尿样本评估尿细胞学。疾病复发定义为非膀胱病变的任何复发,并与膀胱内复发分别编码。
术前184例患者(38.8%)尿细胞学呈阳性。127例患者发生疾病复发,219例患者发生膀胱内复发;83例患者在随访期间死于UTUC。Kaplan - Meier分析显示,只有膀胱内复发的发生率与尿细胞学评估状态显著相关(P = 0.024);RNU后1年和3年,尿细胞学阳性患者的无膀胱内复发生存率分别为61.4%和46.2%,而尿细胞学阴性患者分别为71.1%和51.6%。多变量分析表明,性别(风险比[HR] = 1.74,95%置信区间[CI];1.28 - 2.43)、RNU标本中的肿瘤多灶性(HR = 1.64,95% CI;1.09 - 2.47)和尿细胞学阳性(HR = 1.41,95% CI;1.08 - 1.85)是随后膀胱内复发的独立危险因素。
结果显示了原发性UTUC患者尿细胞学阳性的预后价值,术前尿细胞学阳性可能与RNU后膀胱内复发率的显著增加有关。